These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16872249)

  • 21. Local law enforcement policies directed toward illicit drug selling and usage.
    Grizzle GA
    J Psychoactive Drugs; 1981; 13(3):227-34. PubMed ID: 6801243
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantifying the societal cost of methamphetamine use to Australia.
    Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S
    Int J Drug Policy; 2018 Dec; 62():30-36. PubMed ID: 30352332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-of-illness studies. Useful for health policy?
    Koopmanschap MA
    Pharmacoeconomics; 1998 Aug; 14(2):143-8. PubMed ID: 10186453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician leadership on National Drug Policy finds addiction treatment works.
    Marwick C
    JAMA; 1998 Apr; 279(15):1149-50. PubMed ID: 9555735
    [No Abstract]   [Full Text] [Related]  

  • 25. Harm reduction: concepts and practice. A policy discussion paper.
    Riley D; Sawka E; Conley P; Hewitt D; Mitic W; Poulin C; Room R; Single E; Topp J
    Subst Use Misuse; 1999 Jan; 34(1):9-24. PubMed ID: 10052387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the rhetoric: towards a more effective and humane drug policy framework in South Africa.
    Parry C; Myers B
    S Afr Med J; 2011 Oct; 101(10):704, 706. PubMed ID: 22329014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A drug policy for our times.
    Nahas GG; Frick HC; Gleaton T; Schuchard K; Moulton O
    Bull Narc; 1986; 38(1-2):3-14. PubMed ID: 3779179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economics and drugs: promises, problems, and prospects.
    Harwood HJ
    NIDA Res Monogr; 1991; 113():46-56. PubMed ID: 1762642
    [No Abstract]   [Full Text] [Related]  

  • 30. Our current approach to drug abuse--progress, problems, proposals.
    Kleber HD
    N Engl J Med; 1994 Feb; 330(5):361-5. PubMed ID: 8277959
    [No Abstract]   [Full Text] [Related]  

  • 31. Multi-level governance: The way forward for European illicit drug policy?
    Chatwin C
    Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic costs of drug abuse: financial, cost of illness, and services.
    Cartwright WS
    J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physician Leadership on National Drug Policy: advocacy for an effective drug policy.
    Lewis DC
    Med Health R I; 1999 Mar; 82(3):101-4. PubMed ID: 10193141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of alcohol and drug-involved crime.
    Miller TR; Levy DT; Cohen MA; Cox KL
    Prev Sci; 2006 Dec; 7(4):333-42. PubMed ID: 16845591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
    Fischer B; Murphy Y; Rudzinski K; MacPherson D
    Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use.
    Chisholm D; Doran C; Shibuya K; Rehm J
    Drug Alcohol Rev; 2006 Nov; 25(6):553-65. PubMed ID: 17132573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What drug policies cost: estimating government drug policy expenditures.
    Reuter P
    Addiction; 2006 Mar; 101(3):315-22. PubMed ID: 16499503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absenteeism and business costs: does substance abuse matter?
    Foster WH; Vaughan RD
    J Subst Abuse Treat; 2005 Jan; 28(1):27-33. PubMed ID: 15723729
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.